rs1799864, CCR2

N. diseases: 68
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
HIV-1 infection
CUI: C2363741
Disease: HIV-1 infection
0.070 GeneticVariation BEFREE No association with CCR2b-V64I (17%) and SDF1-3'A (2%) variants was determined in relation to HIV-1 infection in Gabonese patients. 25592723 2015
HIV-1 infection
CUI: C2363741
Disease: HIV-1 infection
0.070 GeneticVariation BEFREE Here, we determined the association of the CCR5 promoter SNPs, the CCR5-Δ32 mutation, CCR2-V64I SNP, and HH frequencies with resistance/susceptibility to HIV-1 infection in a cohort of HIV-1-serodiscordant couples from Colombia. 24098976 2013
HIV-1 infection
CUI: C2363741
Disease: HIV-1 infection
0.070 GeneticVariation BEFREE In addition, we also identified the best three-factor interaction model, including the CCR5 58755-A/G, 59029-A/G, and CCR2-V64I polymorphisms, indicating that there were also strong gene-gene interactions between the CCR5 promoter and CCR2 polymorphisms on the susceptibility of HIV-1 infection. 23057571 2012
HIV-1 infection
CUI: C2363741
Disease: HIV-1 infection
0.070 GeneticVariation BEFREE The meta-analysis clarified that the CCR2-Val64Ile polymorphism has no effect on susceptibility to HIV-1 infection in the total population. 21461583 2011
HIV-1 infection
CUI: C2363741
Disease: HIV-1 infection
0.070 GeneticVariation BEFREE Substitution of V64I in CCR2 relates to delayed progression to AIDS and protects against HIV-1 infection. 17504503 2007
HIV-1 infection
CUI: C2363741
Disease: HIV-1 infection
0.070 GeneticVariation BEFREE Four SNPs (CCR2-V64I, CCR5-2459, MIP1A+954, and IL2+3896) and specific haplotypes in the IL2 and CCR2/CCR5 regions were significantly associated with HIV-1 infection susceptibility in different genetic models. 16323127 2006
HIV-1 infection
CUI: C2363741
Disease: HIV-1 infection
0.070 GeneticVariation BEFREE A single nucleotide polymorphism (SNP) at codon 64 in the CC chemokine receptor 2 gene (CCR2 V64I) has been associated with a dominant effect of delaying disease progression from human immunodeficiency virus-1 (HIV-1) infection to acquired immunodeficiency syndrome (AIDS). 12325020 2002